Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Multicenter Validation of the cppB Gene as a PCR Target for Detection of Neisseria gonorrhoeae

S. M. Bruisten, G. T. Noordhoek, A. J. C. van den Brule, B. Duim, C. H. E. Boel, K. El-Faouzi, R. du Maine, S. Mulder, D. Luijt, J. Schirm
S. M. Bruisten
1Municipal Health Service, GG&GD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sbruisten@gggd.amsterdam.nl
G. T. Noordhoek
2Public Health Laboratory Friesland, LVF, Leeuwarden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. J. C. van den Brule
3Laboratory for Pathology and Microbiology, PAMM, Veldhoven
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Duim
4Department of Medical Microbiology, AMC, Amsterdam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. H. E. Boel
3Laboratory for Pathology and Microbiology, PAMM, Veldhoven
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. El-Faouzi
1Municipal Health Service, GG&GD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. du Maine
4Department of Medical Microbiology, AMC, Amsterdam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Mulder
2Public Health Laboratory Friesland, LVF, Leeuwarden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Luijt
5Regional Public Health Laboratory, SLGD, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Schirm
5Regional Public Health Laboratory, SLGD, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.42.9.4332-4334.2004
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The cppB gene is often used as a target for detection of Neisseria gonorrhoeae by PCR. Using a coded panel of 500 DNA samples, we determined that the cppB gene is missing in 5.8% of N. gonorrhoeae strains, and therefore we consider the cppB gene to be an unsuitable target.

The laboratory diagnosis of gonorrhea depends on identification of Neisseria gonorrhoeae in urogenital samples. Amplification using the Roche COBAS AMPLICOR (CA) assay has been found highly suitable for screening asymptomatic subjects as well as diagnosing gonorrhea in populations with a high prevalence of sexually transmitted infections (STI) (4, 6). Specimens containing other species of the Neisseriaceae, probably members of the normal pharyngeal flora, but also non-Neisseria bacterial strains, were reported to produce false-positive results in the CA PCR test, which targets the cytosine DNA methyltransferase gene (4, 8, 12).

Confirmatory tests using the 16S rRNA genes and the cppB gene have been reported (2, 5, 13, 14); however, the cryptic plasmid on which the cppB gene is located is suspected to be missing in some clinical isolates (11). Therefore, we determined the frequency of the cppB gene in well-characterized N. gonorrhoeae strains cultured from STI patients by using real-time PCR technologies as developed in different diagnostic laboratories in The Netherlands (Table 1).

From September 2002 to April 2003, patients with complaints indicative of gonorrhea visited the STI clinic in Amsterdam, The Netherlands, where clinical and epidemiological data were registered and samples were taken. Urethral, cervical, rectal, or tonsil specimens were used to inoculate GC-Lect agar plates (Becton Dickinson) at the Gemeentelijke Geneeskundige en Gezondheidsdienst (GG&GD). Culture conditions and biochemical determination of N. gonorrhoeae were as described previously (1), including Gram staining, positive catalase reaction, cytochrome c oxidase, and sugar metabolism tests. DNA was isolated from a few colonies by isopropanol precipitation, and the pellet was dissolved in 50 μl of T10 buffer (10 mM Tris-HCl, pH 8.0) (9). In the context of a communal epidemiology study, we typed these N. gonorrhoeae strains by PCR-restriction fragment length polymorphism analysis of the opa and por genes, confirming further that true N. gonorrhoeae strains were used for DNA isolation (7, 10). A coded panel of 500 samples was composed by distributing 50 negative samples randomly among 450 DNA preparations of confirmed N. gonorrhoeae strains. The N. gonorrhoeae-positive samples were prepared by dilution of the original DNA solution to ensure an easily detectable target load. The 50 negative controls consisted of 26 samples containing different buffers, namely, 10× T10 buffer, 5× H2O, 5× phosphate-buffered saline, and 6× AMPLICOR resuspension buffer; 20 samples containing bacterial DNAs derived from non-Neisseria species; and 4 DNA samples from the nongonococcal species N. meningitidis, N. mucosa, N. lactamica, and N. subflava. For each diluted DNA and control sample, five aliquots of 200 μl were prepared and distributed to the participating laboratories by regular mail at room temperature. The samples were analyzed by real-time PCR tests targeting the cppB or the 16S rRNA genes by use of an input of 5 μl of the DNA solution, along with primers, probes, and hardware as outlined in Table 1. The Academisch Medisch Centrum (AMC) performed discrepancy analysis (see below).

After submission of all test results that were obtained in a blinded fashion to the GG&GD, the codes were broken and reported back to the participating laboratories. Each laboratory reset the values for cycle threshold (CT) (for the ABI and RotorGene hardware) and crossing point (Cp) (for the LightCycler), with the results of the negative control samples taken into account. Initially, 459 of 500 (91.8%) results were fully concordant and consisted of 48 negative and 411 N. gonorrhoeae-positive samples. The 41 samples with discordant test results plus 7 negative controls were tested by the AMC to establish whether a sample was truly lacking the cppB gene. If both 16S rRNA tests were positive for a sample but at least three of the four cppB tests were negative, this was taken as proof that the cppB target was lacking.

Two N. gonorrhoeae DNA samples proved to be negative in all tests, probably because they were diluted excessively and were counted as negatives in addition to the 50 negative samples. The SLGD reported two false-positive 16S rRNA test results for the N. meningitidis and N. lactamica samples, yielding 96% specificity. However, when the two samples were retested in the CA test at the Streeklaboratorium voor de Volksgezondheid in Groningen en Drenthe (SLGD), they proved to be negative. Laboratorium voor Pathologie en Medische Microbiologie (PAMM) also reported low Cp values (less than 30) in the 16S rRNA test for these strains, suggesting positivity, but melting-curve analysis with fluorescent resonance energy transfer (FRET) probes showed that these samples were not N. gonorrhoeae. The specificity was 100% for all other tests. The number of discrepant N. gonorrhoeae samples was thus reduced from 41 to 37 (41 minus 2 minus 2) for the six tests (Table 2). For 11 of these 37 samples, a negative result was reported by the 16S rRNA assays and/or by one or two cppB assays, suggesting either a low DNA load or a false-negative result. Thus, for these 11 samples, two to four cppB tests were positive, indicating the presence of a cppB gene. In contrast, in the other 26 N. gonorrhoeae samples, the 16S rRNA assays were positive at both laboratories. In 3 of these 26, only one positive cppB gene result was reported with CT values just below the cutoff, and in the other 23, all four cppB gene tests were negative. These 26 samples were thus discovered to be cppB-lacking N. gonorrhoeae strains, resulting in a proportion of 5.8% (26 of 448) of the N. gonorrhoeae strains tested.

The clinical sensitivities were 98.9 and 99.6% for the 16S rRNA targets at the SLGD and PAMM laboratories, respectively. For the cppB assays, the sensitivities without correction for identifying strains lacking the cppB gene were 92.4, 93.7, and 93.9% at the GG&GD, Laboratorium voor de Volksgezondheid in Friesland (LVF), and SLGD laboratories, respectively, and are thus obviously affected by the lack of a cppB gene in 5.8% of the strains. In a recent CA PCR study in The Netherlands performed directly with clinical samples, a similar proportion of 6% of N. gonorrhoeae strains lacking cppB was found (D. S. Luijt, P. A. J. Bos, A. A. van Zwet, P. C. van Voorst Vader, and J. Schirm, submitted for publication). The present study quantified for the first time the frequency of the cppB gene in a well-defined group of N. gonorrhoeae strains. This gene was found on the cryptic plasmid but may also be present chromosomally in the N. gonorrhoeae genome in cases where the plasmid is integrated. The cryptic plasmid was found to be missing in 4% of N. gonorrhoeae strains collected 25 years ago in the United States and Europe (11) and appeared to be correlated to the PA°U auxotype (3, 8).

Since the sensitivity of a PCR test targeting the cppB gene can never surpass 94%, we conclude that either assays targeting 16S rRNA or alternative PCR assays for detection of N. gonorrhoeae that targets, for example, the highly specific opa genes need to be evaluated in future studies.

View this table:
  • View inline
  • View popup
TABLE 1.

Real-time PCR systems used for analysis

View this table:
  • View inline
  • View popup
TABLE 2.

Samples with discrepant test results (n = 37)

ACKNOWLEDGMENTS

We thank A. Koek and M. Dierdorp for preparation and characterization of all N. gonorrhoeae DNA samples and M. Kolader and colleagues for including the STI patients.

Partial financial support was supplied by Roche Diagnostics, Almere, The Netherlands.

FOOTNOTES

    • Received 19 February 2004.
    • Returned for modification 29 March 2004.
    • Accepted 18 May 2004.
  • Copyright © 2004 American Society for Microbiology

REFERENCES

  1. 1.↵
    Buimer, M., G. J. J. van Doornum, S. Ching, P. G. H. Peerbooms, P. K. Plier, D. Ram, and H. H. Lee. 1996. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by ligase chain reaction-based assays with clinical specimens from various sites: implications for diagnostic testing and screening. J. Clin. Microbiol.34:2395-2400.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Diemert, D. J., M. D. Libman, and P. Lebel. 2002. Confirmation by 16S rRNA PCR of the COBAS AMPLICOR CT/NG test for diagnosis of Neisseria gonorrhoeae infection in a low-prevalence population. J. Clin. Microbiol.40:4056-4059.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Dillon, J. R., and M. Pauzé. 1981. Relationship between plasmid content and auxotype in Neisseria gonorrhoeae isolates. Infect. Immun.33:625-628.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Farrell, D. J. 1999. Evaluation of AMPLICOR Neisseria gonorrhoeae PCR using cppB nested PCR and 16S rRNA PCR. J. Clin. Microbiol.37:386-390.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    Ho, B. S., W. G. Feng, B. K. Wong, and S. I. Egglestone. 1992. Polymerase chain reaction for the detection of Neisseria gonorrhoeae in clinical samples. J. Clin. Pathol.45:439-442.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    Martin, D. H., C. Cammarata, B. Van Der Pol, R. B. Jones, T. C. Quinn, C. A. Gaydos, K. Crotchfelt, J. Schachter, J. Moncada, D. Jungkind, B. Turner, and C. Peyton. 2000. Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae. J. Clin. Microbiol.38:3544-3549.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    O'Rourke, M., C. A. Ison, A. M. Renton, and B. G. Spratt. 1995. Opa-typing: a high-resolution tool for studying the epidemiology of gonorrhoea. Mol. Microbiol.17:865-875.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    Palmer, H. M., H. Mallinson, R. L. Wood, and A. J. Herring. 2003. Evaluation of the specificities of five DNA amplification methods for the detection of Neisseria gonorrhoeae. J. Clin. Microbiol.41:835-837.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    Peerbooms, P. G. H., M. N. Engelen, D. A. J. Stokman, B. H. B. van Benthem, M.-L. van Weert, S. M. Bruisten, A. van Belkum, and R. A. Coutinho. 2002. Nasopharyngeal carriage of potential bacterial pathogens related to day care attendance, with special reference to the molecular epidemiology of Haemophilus influenzae. J. Clin. Microbiol.40:2832-2836.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Rahman, M., A. Alam, K. Nessa, S. Nahar, D. K. Dutta, L. Yasmin, S. Monira, Z. Sultan, S. A. Khan, and M. J. Albert. 2001. Treatment failure with the use of ciprofloxacin for gonorrhea correlates with the prevalence of fluoroquinolone-resistant Neisseria gonorrhoeae strains in Bangladesh. Clin. Infect. Dis. 15.32:884-889.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    Roberts, M., P. Piot, and S. Falkow. 1979. The ecology of gonococcal plasmids. J. Gen. Microbiol.114:491-494.
    OpenUrlCrossRefPubMed
  12. 12.↵
    van Doornum, G. J. J., L. M. Schouls, A. Pijl, I. Cairo, M. Buimer, and S. Bruisten. 2001. Comparison between the LCx Probe system and the COBAS AMPLICOR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in patients attending a clinic for treatment of sexually transmitted diseases in Amsterdam, The Netherlands. J. Clin. Microbiol.39:829-835.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    Van Dyck, E., H. Smet, L. Van Damme, and M. Laga. 2001. Evaluation of the Roche Neisseria gonorrhoeae 16S rRNA PCR for confirmation of AMPLICOR PCR-positive samples and comparison of its diagnostic performance according to storage conditions and preparation of endocervical specimens. J. Clin. Microbiol.39:2280-2282.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    Whiley, D. M., M. E. Crisante, M. W. Syrmis, I. M. Mackay, and T. P. Sloots. 2003. Detection of Neisseria meningitidis by LightCycler PCR. Pathology35:347-349.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Download PDF
Citation Tools
Multicenter Validation of the cppB Gene as a PCR Target for Detection of Neisseria gonorrhoeae
S. M. Bruisten, G. T. Noordhoek, A. J. C. van den Brule, B. Duim, C. H. E. Boel, K. El-Faouzi, R. du Maine, S. Mulder, D. Luijt, J. Schirm
Journal of Clinical Microbiology Sep 2004, 42 (9) 4332-4334; DOI: 10.1128/JCM.42.9.4332-4334.2004

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Multicenter Validation of the cppB Gene as a PCR Target for Detection of Neisseria gonorrhoeae
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Multicenter Validation of the cppB Gene as a PCR Target for Detection of Neisseria gonorrhoeae
S. M. Bruisten, G. T. Noordhoek, A. J. C. van den Brule, B. Duim, C. H. E. Boel, K. El-Faouzi, R. du Maine, S. Mulder, D. Luijt, J. Schirm
Journal of Clinical Microbiology Sep 2004, 42 (9) 4332-4334; DOI: 10.1128/JCM.42.9.4332-4334.2004
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Bacterial Outer Membrane Proteins
Neisseria gonorrhoeae
polymerase chain reaction

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X